𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fascin expression in progression and prognosis of hepatocellular carcinoma

✍ Scribed by Tomohiro Iguchi; Shinichi Aishima; Kenji Umeda; Kensaku Sanefuji; Nobuhiro Fujita; Keishi Sugimachi; Tomonobu Gion; Akinobu Taketomi; Yoshihiko Maehara; Masazumi Tsuneyoshi

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
169 KB
Volume
100
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Prognosis of Primary Hepatocellular Carc
Prognosis of Primary Hepatocellular Carcinoma
✍ Kunio Okuda; Hiroshi Obata; Yukio Nakajima; Toshio Ohtsuki; Nobuo Okazaki; Kunih πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 389 KB

Prognosis of 600 consecutive patients with hepatocellular carcinoma was analyzed in relation to treatment. They were divided into three stages based on four parameters of advanced disease: ascites, tumor greater than 50% of the two-dimensional size of the liver, serum albumin below 3 gm per dl, and

Expression of nm23 in gastric carcinoma
Expression of nm23 in gastric carcinoma : Association with tumor progression and poor prognosis
✍ Wolfram MΓΌller; Anke Schneiders; Gerhard Hommel; Helmut E. Gabbert πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 401 KB πŸ‘ 3 views

## BACKGROUND. Expression of nm23 has been shown to be inversely correlated with the metastatic potential of several human cancers. In the current study, the expression and prognostic impact of nm23 was immunohistochemically studied in 413 curatively resected gastric carcinomas. ## METHODS. Tumor

Adult stem cells in progression and ther
Adult stem cells in progression and therapy of hepatocellular carcinoma
✍ Ingrid Herr; Ariane Groth; Peter Schemmer; Markus W. BΓΌchler πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 278 KB

## Abstract Hepatocellular carcinoma is one of the most aggressive solid tumours associated with poor prognosis. Despite its significance, there is only an elemental understanding of the mechanisms that drive disease pathogenesis, and there are just limited therapy options. The medical community is